IDEXX LABORATORIES INC /DE Quarterly Cost of Revenue in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Idexx Laboratories Inc /De quarterly/annual Cost of Revenue history and growth rate from Q1 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Cost of Revenue for the quarter ending September 30, 2024 was $380M, a 3.25% increase year-over-year.
  • Idexx Laboratories Inc /De Cost of Revenue for the twelve months ending September 30, 2024 was $1.51B, a 4.95% increase year-over-year.
  • Idexx Laboratories Inc /De annual Cost of Revenue for 2023 was $1.47B, a 7.92% increase from 2022.
  • Idexx Laboratories Inc /De annual Cost of Revenue for 2022 was $1.36B, a 2.8% increase from 2021.
  • Idexx Laboratories Inc /De annual Cost of Revenue for 2021 was $1.33B, a 16.8% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.51B $380M +$12M +3.25% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.5B $384M +$13.6M +3.68% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.48B $371M +$13.8M +3.86% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.47B $375M +$31.8M +9.25% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $1.44B $368M +$32.5M +9.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.41B $371M +$24.3M +7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $1.38B $357M +$19.4M +5.75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $1.36B $344M -$1.03M -0.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.36B $335M -$2.47M -0.73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $1.37B $347M +$9.68M +2.87% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $1.36B $338M +$30.9M +10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $1.33B $345M +$33.2M +10.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $1.29B $338M +$38.3M +12.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $1.25B $337M +$78.6M +30.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $1.18B $307M +$40.2M +15.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $1.14B $311M +$37.1M +13.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $1.1B $299M +$38.8M +14.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $1.06B $258M -$4M -1.53% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $1.06B $267M +$22.3M +9.12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $1.04B $274M +$25.3M +10.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $1.02B $260M +$20.5M +8.57% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $996M $262M +$13.9M +5.61% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $982M $244M +$9.9M +4.22% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $972M $249M +$15.4M +6.58% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $956M $240M +$21.8M +10% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $934M $248M +$32.1M +14.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $902M $235M +$30.7M +15.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $872M $234M +$31.3M +15.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $840M $218M +$16.4M +8.13% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $824M $216M +$10.2M +4.95% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $814M $204M +$13.8M +7.27% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $800M $202M +$20.4M +11.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 $780M $202M +$19.5M +10.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $760M $206M +$25.4M +14.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $735M $190M +$23.1M +13.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $712M $182M +$12.2M +7.18% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $699M $182M +$11.9M +7.01% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $688M $181M +$8.98M +5.23% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 $679M $167M +$8.83M +5.58% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $670M $170M +$4.39M +2.65% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $665M $170M +$17.7M +11.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-28
Q2 2014 $648M $172M +$16.7M +10.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $631M $158M +$9.97M +6.73% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $621M $165M +$14.9M +9.92% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-17
Q3 2013 $606M $153M +$7.67M +5.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $598M $155M +$3.93M +2.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-25
Q1 2013 $594M $148M +$230K +0.16% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-25
Q4 2012 $594M $150M +$2.17M +1.46% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-17
Q3 2012 $592M $145M +$2.55M +1.79% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-22
Q2 2012 $589M $151M +$7.13M +4.96% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-23
Q1 2012 $582M $148M +$10.2M +7.37% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23
Q4 2011 $572M $148M +$9.33M +6.72% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-18
Q3 2011 $563M $142M +$14.9M +11.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-19
Q2 2011 $548M $144M +$11.6M +8.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-20
Q1 2011 $536M $138M +$11.6M +9.18% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-20
Q4 2010 $525M $139M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-19
Q3 2010 $127M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-21
Q2 2010 $132M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-22
Q1 2010 $126M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.